The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants
暂无分享，去创建一个
A. Zvi | S. Fleishman | N. Paran | A. Mechaly | E. Mendelson | M. Mandelboim | T. Chitlaru | R. Rosenfeld | O. Mazor | Y. Levy | M. Aftalion | D. Gur | T. Israely | H. Tamir | S. Weiss | E. Epstein | R. Alcalay | S. Shapira | O. Zimhony | S. Yitzhaki | N. Zuckerman | T. Noy-Porat | E. Makdasi | I. Nemet | L. Kliker | Eldar Peretz | A. Tennenhouse | Efi Makdasi | Shay Weiss | Ronit Rosenfeld | Tal Noy-Porat | Moshe Aftalion | David Gur